[go: up one dir, main page]

Larsen et al., 2022 - Google Patents

Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging

Larsen et al., 2022

View HTML
Document ID
4949913997898723391
Author
Larsen B
Cancino A
Shaxted J
Salahudeen A
Publication year
Publication venue
STAR protocols

External Links

Snippet

High-content imaging of tumor organoids (TOs) treated with therapeutic agents provides detailed cell viability readouts at the organoid level. In contrast, most used protocols provide one number per well. While requiring the use of inverted microscopy with an automated …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes

Similar Documents

Publication Publication Date Title
Zhao et al. A 3D printed hanging drop dripper for tumor spheroids analysis without recovery
Sharick et al. Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment
Phan et al. A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Carpentier et al. Angiogenesis analyzer for ImageJ—A comparative morphometric analysis of “endothelial tube formation assay” and “fibrin bead assay”
Gijzen et al. Culture and analysis of kidney tubuloids and perfused tubuloid cells-on-a-chip
Benien et al. 3D tumor models: history, advances and future perspectives
Zanella et al. High content screening: seeing is believing
Thavandiran et al. Functional arrays of human pluripotent stem cell-derived cardiac microtissues
Oraiopoulou et al. Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity
Nguyen et al. Patient-derived tumor organoid rings for histologic characterization and high-throughput screening
Ma et al. A novel 96well-formatted micro-gap plate enabling drug response profiling on primary tumour samples
Roper et al. Establishing an in vitro 3D spheroid model to study medulloblastoma drug response and tumor dissemination
Co et al. Suspended hydrogel culture as a method to scale up intestinal organoids
EP3272852B1 (en) Componential analyzer, drug efficacy analyzer, and analysis method
Larsen et al. Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging
Bregenzer et al. Physiologic patient derived 3D spheroids for anti-neoplastic drug screening to target cancer stem cells
Elpers et al. Agarose‐based 3D cell confinement assay to study nuclear mechanobiology
Burkhart et al. Testing susceptibility of patient-derived organoid cultures to therapies: pharmacotyping
Zuo et al. High-throughput solutions in tumor organoids: from culture to drug screening
Chhetri et al. Cell culture and coculture for oncological research in appropriate microenvironments
Jain et al. Deterministic culturing of single cells in 3D
Pantazi et al. A practical toolkit to study aspects of the metastatic cascade in vitro
US20220349875A1 (en) Method to independently analyze multiple biological processes in encapsulated 3d cell co-cultures
Xu et al. Assessment of hepatotoxicity potential of drug candidate molecules including kinase inhibitors by hepatocyte imaging assay technology and bile flux imaging assay technology
Tan et al. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids